Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

N 0840

Known as: N-0840 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Initial mutagenesis studies exploring the ligand recognition model of A1 adenosine receptor (A1R) mainly focused on the residues… Expand
2004
2004
Novel 3,8- and 8,9-disubstituted N(6)-cyclopentyladenine derivatives were synthesised in moderate overall yield from 6… Expand
Highly Cited
2003
Highly Cited
2003
At nanomolar concentrations, SR141716 and AM251 act as specific and selective antagonists of the cannabinoid CB1 receptor. In the… Expand
Highly Cited
2002
Highly Cited
2002
This report describes the precursor synthesis and the no-carrier-added (nca) radiosynthesis of the new A(1) adenosine receptor (A… Expand
  • figure 1
  • figure 3
  • figure 2
  • figure 4
  • table 1
1999
1999
The purpose of this investigation was to test the hypothesis that A(1) receptors modulate extracellular levels of adenosine in… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 6
Highly Cited
1998
Highly Cited
1998
Receptor antagonists can be classified as neutral antagonists or antagonists with inverse agonist activity based on their… Expand
1993
1993
The pharmacological and biochemical profile of N6-cyclopentyl-9-methyladenine (N-0840) was elucidated in vitro and in vivo. In… Expand